Publication

BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer

Tutt, A
; 
Cheang, M
; 
Kilburn, L
; 
Tovey, H
; 
Gillett, C
; 
Pinder, S
; 
Lanchbury, J
; 
Abraham, J
; 
Barrett, S
; 
Barrett-Lee, P
... show 10 more
Citations
Altmetric:
Abstract
Authors
Tutt, A
Cheang, M
Kilburn, L
Tovey, H
Gillett, C
Pinder, S
Lanchbury, J
Abraham, J
Barrett, S
Barrett-Lee, P
Chan, S
Gazinska, P
Grigoriadis, A
Kernaghan, S
Hoadley, K
Gutin, A
Harper-Wynne, C
Hatton, M
Owen, J
Parker, P
Roylance, R
Shaw, A
Smith, I
Thompson, R
Timms, K
Wardley, Andrew M
Wilson, G
Harries, M
Ellis, P
Ashworth, A
Perou, C
Bliss, J
Rahman, N
Brown, R
Affiliation
Institute of Cancer Research, Breast Cancer Now, London,
Description
Date
2017-02-14
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer 2017, 77 (4 Supplement):S6-01 Cancer Research
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620342
Embedded videos